Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma

Name: Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
Published: 2010
License: Public Domain

M.D. Anderson Cancer Center · 2010

ClinicalTrials.gov · Datasets · License: Public Domain · 2010

Open Source ↗

cisplatin head-and-neck-cancer paclitaxel

head and neck squamous cell carcinoma, head and neck cancer, hnscc, paclitaxel, carboplatin, cetuximab, docetaxel, taxotere, cisplatin, platinol-aq, platinol, cddp

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 852526
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.